ArticleEuropean radiology2026
A modified anterolateral transdiscal percutaneous vertebroplasty with curved needle technique for C2/C3 metastases.
Article in European radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Multiphysics finite element analysis of vertebral stability in simulated osteolytic lumbar defects treated withFrontiers in bioengineering and biotechnology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
objectivePercutaneous vertebroplasty (PVP) for metastases in C2 or C3 vertebrae is limited due to technical challenges and severe adverse events. This study evaluates the efficacy and safety of a modified anterolateral transdiscal approach with curved needle technique for PVP of C2 or C3 metastases. MATERIALS AND
methodsFrom January 2009 to December 2024, patients with metastatic tumors in C2 or C3 vertebrae, who underwent this modified PVP were included in a single-center clinical retrospective study. All patients underwent the procedure under biplane digital subtraction angiography (DSA) guidance with local anesthesia. The primary outcomes focused on pain reduction assessed using the visual analog scale (VAS), while secondary outcomes included cervical spine instability evaluated by the Spinal Instability Neoplastic Score (SINS). The incidence of cement leakage, reduction in analgesic usage, and changes in cervical collar usage rates at 6-month postprocedural were also monitored.
resultsIn total, 54 patients (mean age, 57 years ± 12, 28 men) were evaluated. Sixty-two cervical vertebrae were successfully punctured. Significant improvements in VAS and SINS were observed postprocedurally, indicating effective pain relief and cervical spine stability (p < 0.05). The mean volume of polymethylmethacrylate (PMMA) administered was 3.04 ± 0.77 mL. PMMA leakage was detected in 27 treated vertebrae (43.5%), but without severe adverse events. The patients demonstrated a notable reduction in analgesic consumption and decreased reliance on cervical collars.
conclusionThis modified PVP using an anterolateral transdiscal approach with curved needle technique is a safe and effective treatment for metastatic tumors involving C2 or C3. KEY POINTS: Question Can a modified anterolateral transdiscal approach with curved-needle navigation overcome technical barriers and safety concerns of conventional PVP for C2/C3 metastases? Finding The technique achieved 100% procedural success, significant pain reduction, and cervical spine stability (p < 0.05), 43.5% asymptomatic cement leakage, and reduced analgesic/collar dependency in 54 patients. Clinical relevance This modified anterolateral transdiscal approach with curved-needle PVP enables minimally invasive stabilization of high cervical metastases with a preserved safety profile, offering immediate pain control and cervical spine stability for patients ineligible for surgical intervention.
Indexed as
Identifiers
40779163What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.